Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy
Summary
- Eligibility
- for people ages up to 26 years (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedstudy ends around
- Principal Investigator
- by Lena Winestone
Description
Summary
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Lena Winestone
My research explores racial, ethnic, and socioeconomic outcome disparities for patients with leukemia. I study access to care across the continuum of pediatric cancer from diagnosis and clinical trial enrollment through treatment and relapse to salvage therapies. My research has shown that financial hardship is common at diagnosis and increases over the course of therapy.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Stanford University
- ID
- NCT05865301
- Study Type
- Observational
- Participants
- Expecting 500 study participants
- Last Updated